2025-04-16 – Press Releases – www.prnewswire.com
SHANGHAI, April 16, 2025 /PRNewswire/ — The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the Phase III clinical trial results of ziresovir, a novel RSV-targeted antiviral drug developed by Shanghai Ark…